Three major publishing groups share their insights on the challenges, changes, and opportunities in the highly competitive ...
Congressional leaders met with President Trump at the White House as Washington barrels toward a 2025 shutdown. Follow live ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...
Recently, global investment bank UBS announced that, after crunching some “hard data” from between May and July 2025, there’s ...